Amanote Research
Register
Sign In
223. Lentiviral Vector Mediated Gene Therapy for X-Linked Lymphoproliferative Disease Restores Humoral and Cellular Functions
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)36027-0
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
288. Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatous Disease
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Dual-Regulated Lentiviral Vector for Gene Therapy of X-Linked Chronic Granulomatosis
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
X-Linked Lymphoproliferative Disease (XLP)
316. Integration Site Distribution of Lentiviral Vector in Gene Therapy for X-Adrenoleukodystrophy
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
325. Targeted Gene Addition Strategies for the Treatment of X-Linked Lymphoproliferative Disease
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Gene Therapy for X-Linked Chronic Granulomatous Disease (Net4CGD)
Human gene therapy. Clinical development
Genetics
Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery
Molecular Therapy - Methods and Clinical Development
Molecular Medicine
Genetics
Molecular Biology
267. Development of a New Strategy for X-CGD Gene Therapy Using a miRNA Regulated Lentiviral Vector
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Cytotoxicity Associated With Artemis Overexpression After Lentiviral Vector-Mediated Gene Transfer
Human Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
